Literature DB >> 22155797

A study of symptoms described by ovarian cancer survivors.

Chara Stavraka1, Amy Ford, Sadaf Ghaem-Maghami, Tim Crook, Roshan Agarwal, Hani Gabra, Sarah Blagden.   

Abstract

OBJECTIVE: A cross-sectional, observational study to evaluate physical and psychological symptoms experienced by patients following completion of treatment for ovarian cancer and compared to symptoms documented in their hospital notes.
METHODS: Women attending follow-up clinic at Hammersmith Hospital having undergone treatment for primary or relapsed ovarian cancer were asked to complete two validated questionnaires (EORTC QLQ-C30 and QLQ-OV28) and a "wellbeing thermometer". Results were assessed and stratified by patient age, tumour stage, relapse status, type of chemotherapy received and treatment-free interval. Symptoms reported in questionnaires were compared to those documented in patients' hospital notes.
RESULTS: Of 116 women approached, 100 (86%) participated in this study and had received chemotherapy for ovarian cancer between 2003 and 2010. The most frequently described and severe symptoms reported in the questionnaires were emotional symptoms, negative feelings about treatment or prognosis, fatigue and pain. Dyspareunia, cognitive impairment and peripheral neuropathy were also frequently described. Symptom severity was independent of variables such as disease stage, type of chemotherapy received and relapse status. The "wellbeing thermometer" scores closely correlated with pain, fatigue, weakness, gastrointestinal symptoms and attitude to disease or treatment (p<0.001). There was a marked discordance between questionnaire-reported symptoms and those recorded in hospital notes.
CONCLUSIONS: The majority of women surveyed experienced persistent psychological and physical symptoms following ovarian cancer treatment; in particular: psychological concerns, sexual inactivity and fatigue, all potentially reversible with appropriate interventions. Our results highlight the extent of symptoms described by ovarian cancer survivors and the need for them to be adequately acknowledged and addressed. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22155797     DOI: 10.1016/j.ygyno.2011.12.421

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  20 in total

Review 1.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

2.  Enhancing delivery of small molecule and cell-based therapies for ovarian cancer using advanced delivery strategies.

Authors:  Joanne O'Dwyer; Roisin E O'Cearbhaill; Robert Wylie; Saoirse O'Mahony; Michael O'Dwyer; Garry P Duffy; Eimear B Dolan
Journal:  Adv Ther (Weinh)       Date:  2020-08-16

3.  Coping With Pain Severity, Distress, and Consequences in Women With Ovarian Cancer.

Authors:  Stephanie Gilbertson-White; Grace Campbell; Sandra Ward; Paula Sherwood; Heidi Donovan
Journal:  Cancer Nurs       Date:  2017 Mar/Apr       Impact factor: 2.592

Review 4.  Physical examination of the female cancer patient with sexual concerns: What oncologists and patients should expect from consultation with a specialist.

Authors:  Stacy Tessler Lindau; Emily M Abramsohn; Shirley R Baron; Judith Florendo; Hope K Haefner; Anuja Jhingran; Vanessa Kennedy; Mukta K Krane; David M Kushner; Jennifer McComb; Diane F Merritt; Julie E Park; Amy Siston; Margaret Straub; Lauren Streicher
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

Review 5.  Pain in cancer survivors.

Authors:  Paul A Glare; Pamela S Davies; Esmé Finlay; Amitabh Gulati; Dawn Lemanne; Natalie Moryl; Kevin C Oeffinger; Judith A Paice; Michael D Stubblefield; Karen L Syrjala
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

6.  Symptom management in women with recurrent ovarian cancer: Do patients and clinicians agree on what symptoms are most important?

Authors:  Casey M Hay; Madeleine Courtney-Brooks; Carolyn Lefkowits; Teresa L Hagan; Robert P Edwards; Heidi S Donovan
Journal:  Gynecol Oncol       Date:  2016-08-13       Impact factor: 5.482

Review 7.  Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.

Authors:  Christine D Craig; Bradley J Monk; John H Farley; Dana M Chase
Journal:  Support Care Cancer       Date:  2013-11-10       Impact factor: 3.603

Review 8.  Ovarian cancer survivors' quality of life: a systematic review.

Authors:  D Ahmed-Lecheheb; F Joly
Journal:  J Cancer Surviv       Date:  2016-02-17       Impact factor: 4.442

9.  A study to evaluate the cause of bone demineralization in gynecological cancer survivors.

Authors:  Chara Stavraka; Kate Maclaran; Hani Gabra; Roshan Agarwal; Sadaf Ghaem-Maghami; Alexandra Taylor; Waljit S Dhillo; Nick Panay; Sarah P Blagden
Journal:  Oncologist       Date:  2013-01-30

10.  Chemotherapy-related cognitive dysfunction and effects on quality of life in gynecologic cancer patients.

Authors:  Diana C Pearre; Daniela A Bota
Journal:  Expert Rev Qual Life Cancer Care       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.